These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
361 related articles for article (PubMed ID: 23160379)
1. Claudin-1 induces epithelial-mesenchymal transition through activation of the c-Abl-ERK signaling pathway in human liver cells. Suh Y; Yoon CH; Kim RK; Lim EJ; Oh YS; Hwang SG; An S; Yoon G; Gye MC; Yi JM; Kim MJ; Lee SJ Oncogene; 2013 Oct; 32(41):4873-82. PubMed ID: 23160379 [TBL] [Abstract][Full Text] [Related]
2. Claudin-1 as a promoter of EMT in hepatocellular carcinoma. Stebbing J; Filipović A; Giamas G Oncogene; 2013 Oct; 32(41):4871-2. PubMed ID: 23318416 [TBL] [Abstract][Full Text] [Related]
3. PRRX1 deficiency induces mesenchymal-epithelial transition through PITX2/miR-200-dependent SLUG/CTNNB1 regulation in hepatocellular carcinoma. Chen W; Wu J; Shi W; Zhang G; Chen X; Ji A; Wang Z; Wu J; Jiang C Cancer Sci; 2021 Jun; 112(6):2158-2172. PubMed ID: 33587761 [TBL] [Abstract][Full Text] [Related]
4. Claudin-1 acts through c-Abl-protein kinase Cdelta (PKCdelta) signaling and has a causal role in the acquisition of invasive capacity in human liver cells. Yoon CH; Kim MJ; Park MJ; Park IC; Hwang SG; An S; Choi YH; Yoon G; Lee SJ J Biol Chem; 2010 Jan; 285(1):226-33. PubMed ID: 19897486 [TBL] [Abstract][Full Text] [Related]
5. Clinicopathological significance of ZEB1 protein in patients with hepatocellular carcinoma. Zhou YM; Cao L; Li B; Zhang RX; Sui CJ; Yin ZF; Yang JM Ann Surg Oncol; 2012 May; 19(5):1700-6. PubMed ID: 21584833 [TBL] [Abstract][Full Text] [Related]
6. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma. Meng FD; Wei JC; Qu K; Wang ZX; Wu QF; Tai MH; Liu HC; Zhang RY; Liu C World J Gastroenterol; 2015 Jan; 21(1):196-213. PubMed ID: 25574092 [TBL] [Abstract][Full Text] [Related]
7. 14-3-3ε overexpression contributes to epithelial-mesenchymal transition of hepatocellular carcinoma. Liu TA; Jan YJ; Ko BS; Liang SM; Chen SC; Wang J; Hsu C; Wu YM; Liou JY PLoS One; 2013; 8(3):e57968. PubMed ID: 23483955 [TBL] [Abstract][Full Text] [Related]
8. miR-139-5p inhibits epithelial-mesenchymal transition, migration and invasion of hepatocellular carcinoma cells by targeting ZEB1 and ZEB2. Qiu G; Lin Y; Zhang H; Wu D Biochem Biophys Res Commun; 2015 Jul; 463(3):315-21. PubMed ID: 26022123 [TBL] [Abstract][Full Text] [Related]
9. Comprehensive analysis of the independent effect of twist and snail in promoting metastasis of hepatocellular carcinoma. Yang MH; Chen CL; Chau GY; Chiou SH; Su CW; Chou TY; Peng WL; Wu JC Hepatology; 2009 Nov; 50(5):1464-74. PubMed ID: 19821482 [TBL] [Abstract][Full Text] [Related]
10. Claudins and hepatocellular carcinoma. Wang W; Zhou Y; Li W; Quan C; Li Y Biomed Pharmacother; 2024 Feb; 171():116109. PubMed ID: 38185042 [TBL] [Abstract][Full Text] [Related]
11. MicroRNA-148a suppresses the epithelial-mesenchymal transition and metastasis of hepatoma cells by targeting Met/Snail signaling. Zhang JP; Zeng C; Xu L; Gong J; Fang JH; Zhuang SM Oncogene; 2014 Jul; 33(31):4069-76. PubMed ID: 24013226 [TBL] [Abstract][Full Text] [Related]
12. Overexpression of brachyury contributes to tumor metastasis by inducing epithelial-mesenchymal transition in hepatocellular carcinoma. Du R; Wu S; Lv X; Fang H; Wu S; Kang J J Exp Clin Cancer Res; 2014 Dec; 33(1):105. PubMed ID: 25499255 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma. Huang JY; Zhang K; Chen DQ; Chen J; Feng B; Song H; Chen Y; Zhu Z; Lu L; De W; Wang R; Chen LB Oncotarget; 2015 Jul; 6(21):18613-30. PubMed ID: 26164082 [TBL] [Abstract][Full Text] [Related]
14. Coexpression of gene Oct4 and Nanog initiates stem cell characteristics in hepatocellular carcinoma and promotes epithelial-mesenchymal transition through activation of Stat3/Snail signaling. Yin X; Zhang BH; Zheng SS; Gao DM; Qiu SJ; Wu WZ; Ren ZG J Hematol Oncol; 2015 Mar; 8():23. PubMed ID: 25879771 [TBL] [Abstract][Full Text] [Related]
15. TRPC1/3/6 inhibition attenuates the TGF-β1-induced epithelial-mesenchymal transition in gastric cancer via the Ras/Raf1/ERK signaling pathway. Ge P; Wei L; Zhang M; Hu B; Wang K; Li Y; Liu S; Wang J; Li Y Cell Biol Int; 2018 Aug; 42(8):975-984. PubMed ID: 29570903 [TBL] [Abstract][Full Text] [Related]
16. STYK1 promotes epithelial-mesenchymal transition and tumor metastasis in human hepatocellular carcinoma through MEK/ERK and PI3K/AKT signaling. Wang Z; Qu L; Deng B; Sun X; Wu S; Liao J; Fan J; Peng Z Sci Rep; 2016 Sep; 6():33205. PubMed ID: 27628214 [TBL] [Abstract][Full Text] [Related]
17. Epithelial to mesenchymal transition markers are associated with an increased metastatic risk in primary cutaneous squamous cell carcinomas but are attenuated in lymph node metastases. Toll A; Masferrer E; Hernández-Ruiz ME; Ferrandiz-Pulido C; Yébenes M; Jaka A; Tuneu A; Jucglà A; Gimeno J; Baró T; Casado B; Gandarillas A; Costa I; Mojal S; Peña R; de Herreros AG; García-Patos V; Pujol RM; Hernández-Muñoz I J Dermatol Sci; 2013 Nov; 72(2):93-102. PubMed ID: 23928229 [TBL] [Abstract][Full Text] [Related]